Quinoxalinone as a Privileged Platform in Drug Development

Author(s): Leilei Shi, Wei Hu, Jifeng Wu, Huaiyu Zhou, Hua Zhou, Xun Li*

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 18 , Issue 5 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Among the family of nitrogen-containing heterocycles, quinoxalinone (or quinoxalin-2-one) core, characterized by pyrazin-2(1H)-one fused to benzene ring at two adjacent carbon atoms, has been frequently found in a variety of pharmacologically active compounds with biological or pharmaceutical applications. It was gratifying that a larger part of these bioactive quinoxalinone-based derivatives has entered various clinical trials, which in turn hastens the synthetic versatility and also initiates various derivatization of quinoxalinone scaffold. In this review, we highlighted the newly emerged quinoxalinone- based derivatives or analogues, with the emphasis of their biological applications and structure-activity analysis covering literatures in recent years.

Keywords: Binding mode, biological activities, derivates, quinoxaline, quinoxalinone skeleton, SAR analysis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 14 February, 2018
Page: [392 - 413]
Pages: 22
DOI: 10.2174/1389557517666171101111134
Price: $65

Article Metrics

PDF: 68